CervoMed Inc.
CRVO
$8.28
$0.060.73%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -81.65% | -8.33% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -81.65% | -8.33% | |||
| Cost of Revenue | 18.24% | 5.60% | |||
| Gross Profit | -70.64% | -14.75% | |||
| SG&A Expenses | -28.76% | 37.05% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.09% | 15.98% | |||
| Operating Income | -21.58% | -24.77% | |||
| Income Before Tax | -23.46% | -27.88% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -23.46% | -27.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -23.46% | -27.88% | |||
| EBIT | -21.58% | -24.77% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -19.44% | -24.32% | |||
| Normalized Basic EPS | -19.43% | -24.32% | |||
| EPS Diluted | -19.44% | -24.32% | |||
| Normalized Diluted EPS | -19.43% | -24.32% | |||
| Average Basic Shares Outstanding | 3.38% | 2.85% | |||
| Average Diluted Shares Outstanding | 3.38% | 2.85% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||